ASIATODAY

BIZ&TECH

Samsung Bioepis starts Phase 1 trial for SBE303 ADC

Samsung Bioepis announced Tuesday the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody-drug conjugate (ADC) candidate targeting Nectin-4.SBE303 is designed to bind to Nectin-4, an adhesion protein specifically expressed in tumor cells, including urothelial, lung, and breast cancers. The company said the candidate represents a signi..

Hyundai Motor, Kia on pace to garner W25tr in operating profit
AsiaToday reporter Woo Sung-minHyundai Motor Co and affiliate Kia Corp are expected to record an operating profit of 25 trillion won (US$19.5 billion) for..

previous block

11 12 13 14 15 16 17 18 19 20

next block

Most Read

1

Samsung rides chip super cycle, eyes global No.1 p..

2

Samsung labor seeks 40 trillion won bonus, pressur..

3

SK hynix set to join Samsung surge

4

Hyundai’s 9trn won Saemangeum project gains moment..

5

US-Iran tensions escalate as Trump orders naval bl..

6

Lee to hold summit with Polish PM Tusk on April 13

7

Gulf states rush for Korean air defense systems

PEOPLE

“Hallyu ban to be removed quickly”: Hopes of thaw in Seoul-Beijing ties: · “Efforts will be made to remove Hallyu ban quickly”; · SK Group Chairman heads to Japan to soften “WD risk”

PHOTO

Jang Won-young shines as BVLGARI’s holiday muse

S.KOREA

POLITICS

SOCIAL AFFAIRS

WORLD

CHINA

INDIA

OTHERS

ECONOMY

BIZ&TECH

CULTURE

PEOPLE

PHOTO

Address : In-Young Bldg., 34, Uisadang-daero 1-gil, Yeongdeungpo-gu, Seoul

Copyright by ASIATODAY CO., LTD. All rights resereved